{"id":"NCT02234323","sponsor":"Bioverativ, a Sanofi company","briefTitle":"An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Previously Untreated Males With Severe Hemophilia A","officialTitle":"An Open-Label, Multicenter Evaluation of the Safety and Efficacy of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc; BIIB031) in the Prevention and Treatment of Bleeding in Previously Untreated Patients With Severe Hemophilia A","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-01-12","primaryCompletion":"2019-09-23","completion":"2019-09-23","firstPosted":"2014-09-09","resultsPosted":"2020-08-13","lastUpdate":"2022-04-11"},"enrollment":108,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hemophilia A"],"interventions":[{"type":"BIOLOGICAL","name":"rFVIIIFc","otherNames":["Eloctate; BIIB031; efmoroctocog alfa; recombinant coagulation factor VIII Fc fusion protein; antihemophilic factor [recombinant]","Fc fusion protein"]}],"arms":[{"label":"rFVIIIFc","type":"EXPERIMENTAL"}],"summary":"The primary objective of the study was to evaluate the safety of rFVIIIFc (BIIB031) in previously untreated participants (PUPs) with severe hemophilia A. The secondary objectives were to evaluate the efficacy of rFVIIIFc in the prevention and treatment of bleeding episodes in PUPs, to evaluate rFVIIIFc consumption for the prevention and treatment of bleeding episodes in PUPs, and to describe experience with the use of rFVIIIFc for immune tolerance induction (ITI) in participants with inhibitors.","primaryOutcome":{"measure":"Percentage of Participants With Confirmed Inhibitor Development as Measured by the Nijmegen-Modified Bethesda Assay","timeFrame":"Up to 3 years","effectByArm":[{"arm":"Recombinant Coagulation Factor VIII Fc Fusion Protein","deltaMin":31.11,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"MALE","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":71,"countries":["United States","Australia","Brazil","Canada","France","Germany","Ireland","Italy","Netherlands","New Zealand","Poland","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["38266154","35421219"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":60,"n":103},"commonTop":["Fall","Pyrexia","Nasopharyngitis","Upper respiratory tract infection","Head injury"]}}